$BDMD News

Baird Medical Secures Device Registrations in Vietnam and Advances Regulatory Approval Process in Egypt

Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology

Baird Medical Announces Additional Medical Device Registrations In Vietnam And Preliminary Regulatory Approval In Egypt

Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026

Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

CEO Chat with Mark Saxton, CEO of the U.S. Region of Baird Medical.

BDMD: Baird Medical Reports Strong Revenue Growth for the 6-Month Period Ending 6/30/26

Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026

Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan

Baird Medical Says BD-GT Microwave Ablation System And T-1610 Disposable Microwave Ablation Needle Receive Product Registrations From Drug Regulatory Authority Of Pakistan

BDMD: Baird Medical – Initiation of Leading Microwave Ablation Medical Device Company

Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally

Baird Medical And Tianjin Yuanshan Sign Strategic Cooperation Agreement To Establish Long-Term Partnership Focused On Global Development And Commercialization Of Next-Gen IRE Technologies

Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina

Baird Medical Investment Holdings Completes First Procedures Using Its Microwave Ablation Technology In Vietnam And Argentina

Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion

Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update

Baird Medical Investment FY EPS $(0.98) Down From $0.57 YoY, Sales $22.537M Down From $37.037M YoY

Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia